<DOC>
	<DOC>NCT02946944</DOC>
	<brief_summary>Pilot randomized study of the sidlenafil efficacy in combination with oral anticoagulants in the treatment of patients with intermediate-high risk of pulmonary embolism</brief_summary>
	<brief_title>Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>pulmonary embolism confirmed by CT scan with contrast, with localization of thrombusa in at least one main or proximal lobar pulmonary artery. Rightleft ventricular ratio (RV / LV) â‰¥1 derived from the apical fourchamber view Who gave written informed consent to participate in research Age &lt;18 or &gt;80 years Symptoms of pulmonary embolism&gt; 14 days Inadequate echocardiographic image quality in the apical fourchamber projection, which limits the measurement of RV / LV ratio A significant risk of bleeding The administration of thrombolytic drugs within the previous 4 days Active bleeding Known coagulopathy Thrombocytopenia &lt;100,10^9 / l Previous use of vitamin K antagonists with an INR&gt; 2.5 at admission History of any intracranial or spinal surgery or trauma or intracranial / spinal bleeding Intracranial neoplasm Arteriovenous malformations or aneurysms GIH &lt;3 months Cataract Surgery Obstetrical manipulation Cardiopulmonary resuscitation needed. Other invasive procedures &lt;10 days Allergy, hypersensitivity, thrombocytopenia to heparin or tissue plasminogen activator Allergy to iodine contrast A wellknown rightleft cardiac shunt, for example, a large patent foramen ovale, or atrial septal defect; large (&gt; 10 mm), or a blood clot in right atrium/right ventricle Systolic blood pressure &lt;90 mm Hg for at least 15 minutes, or fall of systolic blood pressure is not less than 40 mm Hg for at least 15 min., with evidence of organ hypoperfusion (cold extremities or low diuresis &lt;30 mL / h, or confusion), or the need for administration of catecholamines to maintain adequate perfusion of organs and systolic blood pressure&gt; 90 mm Hg Severe hypertension (systolic&gt; 180 mm Hg or diastolic&gt; 105 mm Hg.). Pregnancy, lactation, delivery&lt;30 days Participation in any other study (drug or device) Life expectancy &lt;90 days Refusal to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>sildenafil</keyword>
	<keyword>oral anticoagulation therapy</keyword>
</DOC>